Pinnacle Associates’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.76M Buy
1,158,895
+376,530
+48% +$1.82M 0.06% 265
2025
Q4
$5.2M Buy
782,365
+107,490
+16% +$728K 0.07% 246
2025
Q3
$4.14M Sell
674,875
-11,085
-2% -$86.4K 0.06% 273
2025
Q2
$6.32M Buy
+685,960
New +$7.02M 0.09% 203
2019
Q4
Sell
-1,200
Closed -$19K 720
2019
Q3
$19K Buy
+1,200
New +$19.7K ﹤0.01% 701

Other funds holding EOLS

Pinnacle Associates's EOLS Position: Q1 2026 in Review

Pinnacle Associates increased its Evolus (EOLS) stake by 48% in Q1 2026, buying an estimated $1.82M and bringing the position to 1,158,895 shares worth $4.76M. The position accounts for 0.06% of the portfolio, ranked #265.

Pinnacle Associates first reported a position in EOLS in Q3 2019 and has held it in 5 quarters since. The position peaked at $6.32M in Q2 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Pinnacle Associates held 1,158,895 shares of Evolus worth $4.76M as of Q1 2026.
  • Pinnacle Associates bought 376,530 Evolus shares in Q1 2026, an estimated $1.82M.
  • Evolus made up 0.06% of Pinnacle Associates's portfolio in Q1 2026, its #265 holding.
  • Pinnacle Associates first reported a position in Evolus in Q3 2019 and has held it in 5 quarters since.
  • Pinnacle Associates's Evolus position peaked at $6.32M in Q2 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.